DOR BioPharma Forms orBec ® European Medical Advisory Board
< p > Clinical trials are also underway testing allogeneic HSCT for treatment of some metastatic solid tumors such as breast cancer, renal cell carcinoma, melanoma and ovarian cancer. < /p > < p > 09/19/2008 < /p >
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Kidney Cancer | Melanoma | Ovarian Cancer | Ovaries | Renal Cell Carcinoma | Skin Cancer | Urology & Nephrology